Acute Myeloid Leukemia Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Novartis International AG
- Celgene Corporation
- Bristol-Myers Squibb Company
- Amgen Inc.
- AbbVie Inc.
- Eli Lilly and Company
- GlaxoSmithKline plc
- Sanofi-Aventis (Genzyme Corporation)
- Sunesis Pharmaceutical Inc.
The acute myeloid leukemia market consists of several key players who are launching various strategic initiatives to expand their market position in the acute myeloid leukemia industry.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of acute myeloid leukemia is assessed at USD 3.09 billion.
The global acute myeloid leukemia market size was valued at over USD 2.82 billion in 2025 and is expected to expand at a CAGR of around 10.5%, surpassing USD 7.65 billion revenue by 2035.
North America acute myeloid leukemia market will hold around 40% share by 2035, driven by new therapies and rising leukemia incidence.
Key players in the market include Pfizer Inc., Novartis International AG, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., AbbVie Inc., Eli Lilly and Company, GlaxoSmithKline plc, Sanofi-Aventis (Genzyme Corporation), Sunesis Pharmaceutical Inc.
